ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -99.0% | 862 | -98.5% | 0.00% | – |
| Q1 2021 | $97,000 | +36.6% | 57,000 | 0.0% | 0.00% | – |
| Q4 2020 | $71,000 | -12.3% | 57,000 | 0.0% | 0.00% | – |
| Q3 2020 | $81,000 | +17.4% | 57,000 | 0.0% | 0.00% | – |
| Q2 2020 | $69,000 | +3.0% | 57,000 | 0.0% | 0.00% | – |
| Q1 2020 | $67,000 | -44.2% | 57,000 | 0.0% | 0.00% | – |
| Q4 2019 | $120,000 | -31.8% | 57,000 | -28.8% | 0.00% | – |
| Q3 2019 | $176,000 | -12.9% | 80,000 | 0.0% | 0.00% | – |
| Q2 2019 | $202,000 | +173.0% | 80,000 | +240.8% | 0.00% | – |
| Q1 2017 | $74,000 | +21.3% | 23,476 | +0.0% | 0.00% | – |
| Q4 2016 | $61,000 | -33.0% | 23,475 | 0.0% | 0.00% | – |
| Q3 2016 | $91,000 | -8.1% | 23,475 | -36.0% | 0.00% | – |
| Q2 2016 | $99,000 | +130.2% | 36,700 | +262.9% | 0.00% | – |
| Q2 2015 | $43,000 | – | 10,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |